Intravenous fluids for blood bank
Ended Purchase Order Awarded
- Contract number
- HT941025P0054
- Awardee
-
Fenwal, Inc. UEI E9UHXHZCGJV5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $16,609
Award facts
- Contract value 100% obligated
- $16,608.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Agana Heights, Guam
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana Heights, Guam, delivering specialized medical consumables essential to military healthcare infrastructure. The contract aligns with the Defense Health Agency's mission to provide comprehensive healthcare support across the Department of Defense medical enterprise.
This purchase order underscores Fenwal's established role as a key federal supplier of blood collection, separation, storage, and transfusion products. As a registered federal vendor since April 2007, Fenwal has consistently secured contracts across multiple agencies including the National Institutes of Health Clinical Center and the Department of Veterans Affairs. The award reflects the company's competitive capabilities in providing specialized medical products and solutions that support critical healthcare programs within military medical supply chains. The relatively modest contract value is typical for specialized consumable procurements that support ongoing blood banking operations at military medical treatment facilities.
Quick answers
Who was awarded contract HT941025P0054?
HT941025P0054 was awarded to Fenwal, Inc. by Defense Health Agency (Department of Defense) on March 25, 2025.
How much is contract HT941025P0054 worth?
The government has obligated $16,609 on HT941025P0054.
Was contract HT941025P0054 competed?
The extent of competition for HT941025P0054 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award